Evidence map›Paper›PMID 23351704›Full record

ArticleJournal of neuroimmunology2013

Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.

Carey F Li, Raymond W Zhou, Haik Mkhikian, Barbara L Newton, Zhaoxia Yu, Michael Demetriou

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroimmunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The role of glycosylation in clinical allergy and immunology.The Journal of allergy and clinical immunology · 2024
    Review
  5. Immunometabolism (Cobham, Surrey) · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Glycosylation and raft endocytosis in cancer.Cancer metastasis reviews · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carey F LiDepartment of Neurology, University of California, Irvine, CA 92869, USA.
Raymond W Zhou
Haik Mkhikian
Barbara L Newton
Zhaoxia Yu
Michael Demetriou
University of California, Irvine · US

Funding

Human Autoimmunity and Genetic Defects in N-GlycosylationR01AI082266 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DEMETRIOU, MICHAEL · 2010 to 2013
$1.5M
N-glycosylation as a downstream effector of Interleukin-7F30HL108451 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI MKHIKIAN, HAIK · 2011 to 2015
$202k
NHLBI NIH HHS F30 HL108451NHLBI NIH HHS F30HL108451NIAID NIH HHS R01 AI082266NIAID NIH HHS R01AI082266
6 · The paper itself

Abstract

Deficiency of the Golgi N-glycan branching enzyme Mgat5 in mice promotes T cell hyperactivity, endocytosis of CTLA-4 and autoimmunity, including a spontaneous multiple sclerosis (MS)-like disease. Multiple genetic and environmental MS risk factors lower N-glycan branching in T cells. These include variants in interleukin-2 receptor-α (IL2RA), interleukin-7 receptor-α (IL7RA), and MGAT1, a Golgi branching enzyme upstream of MGAT5, as well as vitamin D3 deficiency and Golgi substrate metabolism. Here we describe linked intronic variants of MGAT5 that are associated with reduced N-glycan branching, CTLA-4 surface expression and MS (p=5.79×10(-9), n=7,741), the latter additive with the MGAT1, IL2RA and IL7RA MS risk variants (p=1.76×10(-9), OR=0.67-1.83, n=3,518).

Indexed as

AdultCase-Control StudiesCohort StudiesCTLA-4 AntigenDown-RegulationFemaleFlow CytometryGalactosyltransferasesGenetic VariationHumansMaleMiddle AgedMultiple SclerosisN-AcetylglucosaminyltransferasesReceptors, Interleukin-2Receptors, Interleukin-7CTLA-4 AntigenGalactosyltransferasesN-AcetylglucosaminyltransferasesReceptors, Interleukin-2Receptors, Interleukin-7

Identifiers

PMID23351704
PMCPMC4528623
OpenAlexW2090385083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.